Shubha Bagrodia

Title: Shubha Bagrodia: Innovator in Therapeutic Nanoparticles

Introduction

Shubha Bagrodia is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of therapeutic nanoparticles, holding two patents that showcase his innovative work. His research focuses on the development of nanoparticles that can effectively deliver therapeutic agents.

Latest Patents

Shubha Bagrodia's latest patents include groundbreaking work on therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same. The patents detail nanoparticles that consist of a substantially hydrophobic acid and a therapeutic agent, specifically a compound known as 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, along with pharmaceutically acceptable salts and a polymer. These innovations aim to enhance the efficacy of drug delivery systems.

Career Highlights

Shubha Bagrodia is currently employed at Pfizer Corporation, where he continues to advance his research in therapeutic nanoparticles. His work is pivotal in the development of new treatment methods that can improve patient outcomes.

Collaborations

Shubha collaborates with talented individuals such as Jennifer A Lafontaine and Zach Lovatt, who contribute to the innovative environment at Pfizer Corporation.

Conclusion

Shubha Bagrodia is a notable inventor whose work in therapeutic nanoparticles is paving the way for advancements in medical treatments. His contributions are essential in the ongoing quest for effective drug delivery systems.